B

Baroness Martin of Brockley (Lab)

Speaking in the House of Lords on 13 October 2026

Debate

Health Bill

Contribution

My Lords, it sounds like I am not alone in broadly welcoming the Bill. Many of its ambitions, not least the single patient record, are ones that I strongly support. Done well, the SPR will transform patient care, streamline decision-making and help realise the potential of the UK’s incredible health data, so I am delighted that this Government are grasping the nettle and getting on with it. The SPR helps to pave the way to use technology, specifically AI, more effectively to spot disease earlier, to personalise treatment and to help people stay well for longer. I would like us all to think more ambitiously about AI in health and across our public services. But today I want to focus my remarks on two opportunities created by this Bill that can help support our economy. The first is research. Commercial clinical trials are a crucial feature of our health system. Just this morning I was at the Oak Cancer Centre at the Royal Marsden where they are researching and testing cutting-edge treatments that will improve survival rates and can transform the quality of life of cancer patients. However, clinical trials are important not only for patient outcomes. According to research for the ABPI by Frontier Economics, in 2022 alone industry clinical trials generated £7.4 billion-worth of GVA for the UK economy and created 65,000 jobs. The Bill rightly places a new duty on the Secretary of State to promote innovation, but it is essential that this duty at the top translates into delivery on the ground. That is why we need robust accountability mechanisms to ensure that ICBs build real capacity for clinical trial infrastructure. How will the Secretary of State work with ICBs to deliver on this vital duty? The second opportunity is how we use health spending to help grow our economy. Health is one of the largest areas of public spending in this country. How that money is spent is one of the most powerful levers the Government possess to support innovation, back UK entrepreneurs and create good jobs in every part of the country. The Prime Minister understands this. At the innovation summit in Manchester on Friday, he was clear that this Government will, in his words, “make British public procurement work harder”. Indeed, the First Secretary of State has already taken welcome steps to reform central government procurement rules, and through the life sciences sector plan and DHSC’s SME action plan the direction of travel is clear. My concern is whether this Bill does enough to support the Government’s goal to use procurement to strengthen our economy. As I have discovered over several increasingly acronym-heavy weeks, health procurement is pretty complicated, but the thing that is clear is that the Bill transfers vast commissioning responsibilities from NHS England to ICBs. The DHSC’s figures show that ICBs will control around 93% of NHS healthcare commissioning budgets. That is about £179 billion in the next financial year alone. That represents huge purchasing power. I asked my noble friend the Minister in correspondence whether ICBs fall within the Government’s SME procurement targets. I am grateful for her reply, but, sadly, it confirmed that they do not. That is not the only area where there is a risk of a mismatch between rhetoric and action. When asked whether it would encourage contracts for the single patient record to be awarded to UK firms, the DHSC said that this was a matter for the Cabinet Office and that it was taking a “supplier-agnostic approach”. I understand and totally respect the importance of open competition, but if our flagship health technology programme cannot be used to back homegrown innovation, what can? I ask my noble friend the Minister whether the department will consider a system-wide stocktake of how health commissioning and procurement can better support UK enterprise and innovation so that this House and the public can see where the opportunities lie and how we can realise them. Both points come down to a single principle: turning ambition into delivery. This Government have set out bold goals for an innovative NHS and for public procurement that drives British growth. I support both wholeheartedly, and I look forward to working constructively with my noble friend to help make them happen.

More from Baroness Martin of Brockley (Lab)

Other recent Hansard contributions by the same speaker.

About Hansard

Hansard is the official verbatim record of proceedings in the UK Parliament. Every word spoken in the Commons and Lords is recorded and published — this page is a single contribution from that record.